Genomic Medicine Department, GENYO, Centre for Genomics and Oncological Research, Pfizer-University of Granada-Andalusian Regional Government, Parque Tecnológico Ciencias de la Salud, Av. de la Ilustración 114, 18016 Granada, Spain.
Department of Medicinal & Organic Chemistry and Excellence Research Unit of "Chemistry Applied to Biomedicine and the Environment", Faculty of Pharmacy, University of Granada, Campus de Cartuja s/n, 18071, Granada, Spain.
Cells. 2020 Jun 18;9(6):1492. doi: 10.3390/cells9061492.
In spite of the enormous potential of CRISPR/Cas in basic and applied science, the levels of undesired genomic modifications cells still remain mostly unknown and controversial. Nowadays, the efficiency and specificity of the cuts generated by CRISPR/Cas is the main concern. However, there are also other potential drawbacks when DNA donors are used for gene repair or gene knock-ins. These GE strategies should take into account not only the specificity of the nucleases, but also the fidelity of the DNA donor to carry out their function. The current methods to quantify the fidelity of DNA donor are costly and lack sensitivity to detect illegitimate DNA donor integrations. In this work, we have engineered two reporter cell lines (K562_SEWAS84 and K562GWP) that efficiently quantify both the on-target and the illegitimate DNA donor integrations in a -locus targeting setting. K562_SEWAS84 cells allow the detection of both HDR-and HITI-based donor integration, while K562GWP cells only report HDR-based GE. To the best of our knowledge, these are the first reporter systems that allow the use of gRNAs targeting a relevant locus to measure efficacy and specificity of DNA donor-based GE strategies. By using these models, we have found that the specificity of HDR is independent of the delivery method and that the insertion of the target sequence into the DNA donor enhances efficiency but do not affect specificity. Finally, we have also shown that the higher the number of the target sites is, the higher the specificity and efficacy of GE will be.
尽管 CRISPR/Cas 在基础科学和应用科学方面具有巨大的潜力,但细胞中不受欢迎的基因组修饰水平仍然大多未知且存在争议。如今,CRISPR/Cas 产生的切割的效率和特异性是主要关注点。然而,当 DNA 供体用于基因修复或基因敲入时,也存在其他潜在的缺点。这些基因编辑策略不仅应考虑到核酸酶的特异性,还应考虑到 DNA 供体进行其功能的保真度。目前用于量化 DNA 供体保真度的方法既昂贵又缺乏检测非合法 DNA 供体整合的敏感性。在这项工作中,我们构建了两个报告细胞系(K562_SEWAS84 和 K562GWP),它们能够有效地在靶向 - 基因座的设置中定量检测靶标和非合法 DNA 供体的整合。K562_SEWAS84 细胞允许检测基于 HDR 和 HITI 的供体整合,而 K562GWP 细胞仅报告基于 HDR 的基因编辑。据我们所知,这些是第一个允许使用靶向相关基因座的 gRNA 来测量基于 DNA 供体的基因编辑策略的功效和特异性的报告系统。通过使用这些模型,我们发现 HDR 的特异性独立于递送方法,并且将目标序列插入 DNA 供体中会提高效率但不影响特异性。最后,我们还表明,目标位点的数量越多,基因编辑的特异性和效率就越高。